Login
$AGMB
$8.40 -$0.17 (1.98%) Close

Company Executives

$AGMB Management Team

Mr. David Epstein

Independent Chairman of the Board

Age 64
Compensation -
Sex Male

Mr. Tim Knotnerus

Chief Executive Officer

Executive Director

Age 43
Compensation -
Sex Male

Mr. Pierre Kemula

Chief Financial Officer

Age 52
Compensation -
Sex Male

Mrs. Ellen Lefever

General Counsel

Age 41
Compensation -
Sex Female

Dr. Andrea Saez

Chief Development Officer

Age 45
Compensation -
Sex Female

Dr. Paul van der Horst

Chief Business Officer

Age 38
Compensation -
Sex Male

Dr. Philippe Wiesel

Chief Medical Officer

Age 59
Compensation -
Sex Male

Board of Directors

No proxy statement on record

Board of Directors comes from the company’s proxy statement. Agomab Therapeutics NV has not filed one with the SEC.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Agomab Therapeutics NV has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support